| |
| healthcare |
MOPH reiterates precautionary measures against COVID-19
July 13, 2020
Doha: Ministry of Public Health (MOPH) emphasized the need to follow the general precautionary measures against the Coronavirus. On its Twitter page, MOPH reminded people of Qatar to maintain physical distance of at least 1.5 meters between people. For indoor venues, a space of at least 9 m2 should also be observed for each person. To prevent transmission, MOPH also encourages"...
7 آلاف استشارة باطنية هاتفية بمستشفى حمد
July 12, 2020
كشف الدكتور علي إبراهيم رحيل استشاري أول أمراض الباطنة بمؤسسة حمد الطبية عن تقديم 7452 استشارة هاتفية للمرضى المراجعين بقسم الباطنة بمستشفى حمد العام خلال الفترة من 15 مارس الماضي وحتى 6 يوليو الجاري، وذلك من خلال العيادات الافتراضية التي يتم من خلالها التواصل مع المرضى بدلاً من حضورهم للعيادات. "...
HMC advises to take safety measures as mercury surges
July 12, 2020
As summer temperature continues to rise, Hamad Medical Corporation (HMC) has stressed the importance of community members taking the necessary measures and precautions. In a social media campaign, HMC has warned members of the public about the dangers of leaving children alone in vehicles. “Do not leave children unattended at parking slots,” it said. “A"...
Takeda Provides Updates on Its Pharmacokinetic-guided Prophylaxis Studies at ISTH 2020, Reinforcing Its Commitment to Advancing Personalized Care for People with Bleeding Disorders
July 12, 2020
Takeda Pharmaceutical Company Limited (“Takeda”) (TSE: 4502/NYSE:TAK) today announced that 13 abstracts are being presented from the company’s Hematology portfolio and pipeline at the International Society on Thrombosis and Haemostasis 2020 Virtual Congress (ISTH 2020). Among the data, Takeda spotlighted four abstracts to highlight its commitment to advancing personalized care through pharmacokinetic (PK)-guided prophylaxis in people living with hemophilia or von Willebrand Disease (VWD) – including scientific updates in patients with hemophilia A from the Phase 3 PROPEL and Phase 3b CONTINUATION studies investigating potential benefits of personalized TAK-660 (rurioctocog alfa pegol) prophylaxis. Two population studies into the PK/pharmacodynamic (PD) profiles of recombinant von Willebrand factor (rVWF), which provide data to assist in the optimization of rVWF personalized......
New Evidence Shows Morinaga Milk’s Probiotic Bifidobacterium breve A1 Improves Memory of Older Adults With Cognitive Dysfunction
July 10, 2020
Morinaga Milk Industry Co., Ltd. (TOKYO:2264), a leading Japanese dairy product company and a key global probiotics manufacturer, confirmed that its proprietary probiotic strain Bifidobacterium breve A1 (a.k.a. B. breve MCC1274) is safe and effective for improving memory functions of older adults with suspected mild cognitive impairment (MCI) in a randomized, double-blind, placebo-controlled trial (RCT). The new study, published recently in the Journal of Alzheimer’s Disease, has produced breakthrough results uncovering a novel promising probiotic intervention for early dementia prevention. The clinical study conducted by a clinical research organization, Huma R&D Co., Ltd. in Tokyo, Japan, in collaboration with Morinaga Milk Industry Co., Ltd, is the first RCT report to show a profound cognitive enhancement benefit of the probiotic B. breve A1 in subjects with suspected MCI. “Our......
Laboratory Studies Confirm BETADINE® Antiseptic Products’ Effectiveness Against COVID-19 Virus
July 10, 2020
Mundipharma today announced that laboratory testing at the Duke-NUS Medical School in Singapore, has confirmed the effectiveness of its BETADINE® antiseptic products against the novel coronavirus (SARS-CoV-2) which causes COVID-19 disease. Testing has demonstrated BETADINE’s® strong in-vitro virucidal activity, killing 99.99% of the SARS-CoV-2 virus in 30 seconds. The products subjected to testing were: BETADINE® antiseptic products,"...
Sheikha Moza attends inauguration of WHO Collaborating Center at WCM-Q
July 9, 2020
Her Highness Sheikha Moza bint Nasser, Chairperson of Qatar Foundation for Education, Science and Community Development (QF), attended an event marking the official designation of a research group at Weill Cornell Medicine-Qatar (WCM-Q) as a World Health Organization (WHO) Collaborating Centre for combating COVID-19 and other selected infectious diseases in the region.
Under the new designation, the Infectious Disease Epidemiology Group (IDEG) at WCM-Q will support WHO’s regional and global efforts to promote"...
New Index: A Young Population Has Been Africa’s Best Defense Against COVID-19 Deaths So Far, But Several Regions Are Dangerously Vulnerable
July 9, 2020
A new index designed to fill a critical information gap and help African governments, health officials, non-governmental organizations, and others respond to the coronavirus pandemic finds that although Africa has not yet been overwhelmed by COVID-19, several regions are showing troubling signs of vulnerability to the social, economic, and health impacts of an outbreak that should not be ignored. The Africa COVID-19 Community Vulnerability Index"...
New AMR Action Fund Steps in to Save Collapsing Antibiotic Pipeline With Pharmaceutical Industry Investment of US$1 Billion
July 9, 2020
Today, more than 20 leading biopharmaceutical companies announced the launch of the AMR Action Fund [www.AMRactionfund.com], a ground-breaking partnership that aims to bring 2-4 new antibiotics to patients by 2030. These treatments are urgently needed to address the rapid rise of antibiotic-resistant infections"...
Takeda and the New York Academy of Sciences Announce 2020 Innovators in Science Award Winners
July 8, 2020
Takeda Pharmaceutical Company Limited (“Takeda”) (TSE:4502/NYSE:TAK) and the New York Academy of Sciences announced today the Winners of the third annual Innovators in Science Award for their excellence in and commitment to innovative science that has significantly advanced the field of rare disease research. Each Winner receives a prize of US $200,000. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200708005039/en/ The 2020 Winner of the Senior Scientist Award is Adrian R. Krainer, Ph.D., St. Giles Foundation Professor at Cold Spring Harbor Laboratory. Prof. Krainer is recognized for his outstanding research on the mechanisms and control of RNA splicing, a step in the normal process by which genetic information in DNA is converted into proteins. Prof. Krainer studies splicing defects in patients with spinal muscular......
|
|
|
|
|